Correspondence 0001493152-24-035688 from Vitro Biopharma, Inc. (VTRO) (CIK 0000793171)
Vitro Biopharma, Inc. (VTRO) (CIK 0000793171)
Date: Sept. 10, 2024 · CIK: 0000793171 · Accession: 0001493152-24-035688
AI Filing Summary & Sentiment
File numbers found in text: 333-267366
Letter
Vitro Biopharma, Inc.
Cherry Creek Drive South, Suite 410
Denver, Colorado 80209
September 10, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
F Street N.E.
Washington, D.C. 20549
Re: Vitro Biopharma, Inc.
Registration Statement on Form S-1
File No. 333-267366
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Vitro Biopharma, Inc. hereby respectfully requests acceleration of the effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 4:30 p.m. Eastern Time, on September 11, 2024, or as soon as practicable thereafter.
Very truly yours,
Vitro Biopharma, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Vitro
Biopharma, Inc.
3200
Cherry Creek Drive South, Suite 410
Denver,
Colorado 80209
September
10, 2024
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street N.E.
Washington,
D.C. 20549
Re:
Vitro
Biopharma, Inc.
Registration
Statement on Form S-1
File
No. 333-267366
Ladies
and Gentlemen:
Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, Vitro Biopharma, Inc. hereby respectfully requests acceleration
of the effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 4:30
p.m. Eastern Time, on September 11, 2024, or as soon as practicable thereafter.
Very truly yours,
Vitro Biopharma, Inc.
By:
/s/ Christopher Furman
Christopher Furman
Chief Executive Officer